The Galleri Multi-Cancer Early Detection (MCED) Test Increased Cancer Detection 6.5 Fold When Added to Recommended Screenings for Breast, Colorectal, Cervical and Lung Cancer
No Reduction Observed in Combined Primary Endpoint of Stage III/IV Cancers in Aggregate; However, Decreases Observed Beyond the Prevalent Screening Round Â
MENLO PARK, Calif. , May 27, 2026 /PRNewswire/ --Â GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted...
MENLO PARK, Calif. , May 26, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
MENLO PARK, Calif. , May 21, 2026 /PRNewswire/ --Â GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified...
Barchart Research What to Expect from GRAL Earnings GRAL Generated May 4, 2026 Current Price $55.66 EPS Estimate $$-3.00 Consensus Rating Moderate Buy Average Move 14.27% GRAIL's Revenue Growth Continues,...
/PayPal%20Holdings%20Inc%20sign%20on%20building-%20by%20Sundry%20Photography%20via%20Shutterstock.jpg)
PYPL stock has a very low valuation and multiple, powerful, potential catalysts. Here's what else to know ahead of its Q1 earnings.
MENLO PARK, Calif. , April 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
MENLO PARK, Calif. , April 22, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue...